Geode Capital Management, LLC Neuro Bo Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.72 - $1.54 $4,896 - $10,472	6,800 Added 11.63%	65,290 $58,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $2.5 $2,808 - $5,755	-2,302 Reduced 3.79%	58,490 $71,000
Q3 2021 Nov 12, 2021	BUY	$2.73 - $4.52 $45,105 - $74,679	16,522 Added 37.32%	60,792 $226,000
Q2 2021 Aug 13, 2021	BUY	$2.74 - $4.63 $4,162 - $7,032	1,519 Added 3.55%	44,270 $147,000
Q1 2021 May 12, 2021	BUY	$3.93 - $6.68 $5,726 - $9,732	1,457 Added 3.53%	42,751 $188,000
Q4 2020 Feb 12, 2021	BUY	$5.02 - $6.59 $818 - $1,074	163 Added 0.4%	41,294 $216,000
Q3 2020 Nov 13, 2020	BUY	$5.41 - $8.67 $1,006 - $1,612	186 Added 0.45%	41,131 $231,000
Q2 2020 Aug 13, 2020	BUY	$8.05 - $29.44 $329,607 - $1.21 Million	40,945 New	40,945 $329,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.